• Home   /  
  • Archive by category "1"

N Acetyl Cysteine Synthesis Essay

1. Youssef G, Meguid Ali A, Alaa N, Makin B, Waly M, AbouSetta A. N-acetyl-cysteine in anovulatory women: the impact of postcoital test. Middle East Fertil Soc J. 2006;11:109–112.

2. Larsson SC, Håkansson N, Wolk A. Dietary cysteine and other amino acids and stroke incidence in women. Stroke. 2015;46(4):922–926.[PubMed]

3. Shahin AY, Hassanin IM, Ismail AM, Kruessel JS, Hirchenhain J. Effect of oral N-acetyl cysteine on recurrent preterm labor following treatment for bacterial vaginosis. Int J Gynaecol Obstet. 2009;104(1):44–48.[PubMed]

4. Amin AF, Shaaban OM, Bediawy MA. N-acetyl cysteine for treatment of recurrent unexplained pregnancy loss. Reprod Biomed Online. 2008;17(5):722–726.[PubMed]

5. Elgindy EA, El-Huseiny AM, Mostafa MI, Gaballah AM, Ahmed TA. N-acetyl cysteine: could it be an effective adjuvant therapy in ICSI cycles?. A preliminary study. Reprod Biomed Online. 2010;20(6):789–796.[PubMed]

6. Agarwal A, Allamaneni SSR. Oxidants and antioxidants in human fertility. Middle East Fertil Soc J. 2004;9(3):187–197.

7. Wang Q, Hou Y, Yi D, Wang L, Ding B, Chen X, et al. Protective effects of N-acetyl cysteine on acetic acid-induced colitis in a porcine model. BMC Gastroenterol. 2013;13:133–133.[PMC free article][PubMed]

8. Nasr A. Effect of N-acetyl cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study. Reprod Biomed Online. 2010;20(3):403–409.[PubMed]

9. Moini A, Tadayon SH, Tehranian A, Mohammadi Yeganeh L, Akhoond MR, Salman Yazdi R. Association of thrombophilia and polycystic ovarian syndrome in women with history of recurrent pregnancy loss. Gynecol Eendocrinol. 2012;28(8):590–593.[PubMed]

10. Moini A, Javanmard F, Eslami B, Aletaha N. Prevalence of metabolic syndrome in polycystic ovarian syndrome women in a hospital of Tehran. Iran J Reprod Med. 2012;10(2):127–130.[PMC free article][PubMed]

11. Moini A, Eslami B. Familial associations between polycystic ovarian syndrome and common diseases. J Assist Reproduction Genet. 2009;26(2-3):123–127.[PMC free article][PubMed]

12. Sekhon LH, Gupta S, Kim Y, Agarwal A. Female infertility and antioxidants. Curr Womens Health Rev. 2010;6:84–95.

13. Woods JR. Reactive oxygen species and preterm premature rupture of membranes a review. Placenta. 2001;22(Suppl A):S38–44.[PubMed]

14. Mercer BM, Goldenberg RL, Das A, Moawad AH, Iams JD, Meis PJ. The preterm prediction study: a clinical risk assessment system. Am J Obstet Gynecol. 1996;174(6):1885–1893.[PubMed]

15. American College of Obstetricians and Gynecologists. ACOG practice bulletin.Management of recurrent pregnancy loss.Number 24, February 2001.(Replaces Technical Bulletin Number 212, September 1995).American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002;78(2):179–190.[PubMed]

16. Poston L, Raijmakers MT. Trophoblast oxidative stress, antioxidants and pregnancy outcome--a review. Placenta. 2004;25(Suppl A):S72–78.[PubMed]

17. Mohammad Seyedhassani S, Houshmand M, Mehdi Kalantar S, Aflatoonian A, Modabber G, Hashemi Gorgi F, et al. BAX pro-apoptotic gene alterations in repeated pregnancy loss. Arch Med Sci. 2011;7(1):117–122.[PMC free article][PubMed]

18. Zahraei M, Sheikhha MH, Kalantar SM, Ghasemi N, Jahaninejad T, Rajabi S, et al. The association of arylendosulfatase 1 (SULF1) gene polymorphism with recurrent miscarriage. J Assist Reprod Genet. 2014;31(2):157–161.[PMC free article][PubMed]

19. Seyedhassani SM, Houshmand M, Kalantar SM, Modabber G, Aflatoonian A. No mitochondrial DNA deletions but more D-loop point mutations in repeated pregnancy loss. J Assist Reprod Genet. 2010;27(11):641–648.[PMC free article][PubMed]

20. Harada M, Kishimoto K, Furuhashi T, Naito K, Nakashima Y, Kawaguchi Y, et al. Infertility observed in reproductive toxicity study of N-acetyl L-cysteine in rats. Biol Reprod. 2003;69(1):242–247.[PubMed]

21. Crowell C, Lyew RV, Givens M. Caring for the mother, concentrating on the fetus: intravenous N-acetyl cysteine in pregnancy. Am J Emerg Med. 2008;26(6):735–735. e1-735e2. [PubMed]

22. Green JL, Heard KJ, Reynolds KM, Albert D. Oral and intravenous acetylcysteine for treatment of acetaminophen toxicity: A systematic review and meta-analysis. West J Emerg Med. 2013;14(3):218–226.[PMC free article][PubMed]

23. Beloosesky R, Gayle DA, Amidi F, Nunez SE, Babu J, Desai M, et al. N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats. Am J Obstet Gynecol. 2006;194(1):268–273.[PubMed]

24. Paintlia MK, Paintlia AS, Singh AK, Singh I. Attenuation of lipopolysaccharide-induced inflammatory response and phospholipids metabolism at the feto-maternal interface by N-acetyl cysteine. Pediatr Res. 2008;64(4):334–339.[PMC free article][PubMed]

25. Beloosesky R, Weiner Z, Khativ N, Maravi N, Mandel R, Boles J, et al. Prophylactic maternal n-acetylcysteine before lipopolysaccharide suppresses fetal inflammatory cytokine responses. Am J Obstet Gynecol. 2009;200(6):665–665. e1-665e1-5. [PubMed]

26. Cheraghi E, Mehranjani MS, Shariatzadeh MA, Nasr Esfahani MH, Ebrahimi Z. Co-administration of metformin and n-acetyl cysteine fails to improve clinical manifestations in pcos individual undergoing icsi. Int J Fertil Steril. 2014;8(2):119–128.[PMC free article][PubMed]

27. Rizk AY, Bedaiwy MA, Al-Inany HG. Clomiphene-acetyl cysteine combination as a new protocol to a friendly IVF cycle. Middle East Fertil Soc J. 2005;10(2):130–134.

28. Larson M. Clinical recognition of N-acetyl cysteine in chronic bronchitis. Eur Respir Rev. 1992;2(7):5–8.

29. Tunek A. Possible mechanisms behind the anti-inflammatory effects of N-acetyl cysteine; is metabolism essential? Eur Respir Rev. 1992;2(7):35–38.

30. Stey C, Steurer J, Bachmann S, Medici TC, Tramèr MR. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J. 2000;16(2):253–262.[PubMed]

31. Sadowska AM, Manuel-Y-Keenoy B, De Backer WA. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo doseeffects: a review. Pulm Pharmacol Ther. 2007;20(1):9–22.[PubMed]

32. Jones DP, Maellaro E, Jiang S, Slater AF, Orrenius S. Effects of N-acetyl-L-cysteine on T-cell apoptosis are not mediated by increased cellular glutathione. Immunol Lett. 1995;45(3):205–209.[PubMed]

33. Cai T, Fassina G, Morini M, Aluigi MG, Masiello L, Fontanini G, et al. N-acetylcysteine inhibits endothelial cell invasion and angiogenesis. Lab Invest. 1999;79(9):1151–1159.[PubMed]

34. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Ciccolo A, Centorrino T, et al. Protective effects of N-acetyl cysteine on lung injury and red blood cell modification induced by carrageenan in the rat. FASEB J. 2001;15(7):1187–1200.[PubMed]

35. Kretzman NA, Chiela E, Matte U, Marroni N, Marroni CA. N-acetylcysteine improves antitumoural response of interferon alpha by NF-kB downregulation in liver cancer cells. Comp Hepatol. 2012;11(1):4–4.[PMC free article][PubMed]

36. Goldstein D, Laszlo J. The role of interferon in cancer therapy: a current perspective. CA Cancer J Clin. 1988;38(5):258–277.[PubMed]

37. Wanamarta AH, van Rijn J, Blank LE, Haveman J, van Zandwijk N, Joenje H. Effect of N-acetyl cysteine on the antiproliferative action of X-rays or bleomycin in cultured human lung tumor cells. J Cancer Res Clin Oncol. 1989;115(4):340–344.[PubMed]

38. Millea PJ. N-acetyl cysteine: multiple clinical applications. Am Fam Physician. 2009;80(3):265–269.[PubMed]

39. Moreno-Otero R, Trapero-Marugn M. Hepatoprotective effects of antioxidants in chronic hepatitis C. World J Gastroenterol. 2010;16(15):1937–1938.[PMC free article][PubMed]

40. Kerksick C, Willoughby D. The antioxidant role of glutathione and N-acetyl cysteine supplements and exerciseinduced oxidative stress. J Int Soc Sports Nutr. 2005;2(2):38–44.[PMC free article][PubMed]

41. Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res. 2007;4(2):143–150.[PubMed]

42. Khosravi M, Shohrati M, Falaknazi K. Does N-acetyl cysteine have a dose-dependent effect on plasma homocysteine concentration in patients undergoing hemodialysis? Int J Nephrol Urol. 2009;1(1):27–32.

43. Song DJ, Min MG, Miller M, Cho JY, Broide DH. Environmental tobacco smoke exposure does not prevent corticosteroids reducing inflammation, remodeling, and airway hyperreactivity in mice exposed to allergen. Am J Physiol Lung Cell Mol Physiol. 2009;297(2):L380–387.[PMC free article][PubMed]

44. Li JJ, Wang W, Baines KJ, Bowden NA, Hansbro PM, Gibson PG, et al. IL-27/IFN-γ induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages. J Immunol. 2010;185(7):4401–4409.[PubMed]

45. Eftekhari P, Hajizadeh S, Raofy MR, Masjedi MR, Yang M, Hansbro N, et al. Preventive effect of N-acetylcysteine in a mouse model of steroid resistant acute exacerbation of asthma. Excli J. 2013;12:184–192.[PMC free article][PubMed]

46. Blesa S, Cortijo J, Mata M, Serrano A, Closa D, Santangelo F, et al. Oral N-acetyl cysteine attenuates the rat pulmonary inflammatory response to antigen. Eur Respir J. 2003;21(3):394–400.[PubMed]

47. Blesa S, Cortijo J, Martinez-Losa M, Mata M, Seda E, Santangelo F, et al. Effectiveness of oral N-acetyl cysteine in a rat experimental model of asthma. Pharmacol Res. 2002;45(2):135–140.[PubMed]

48. Markesbery WR. The role of oxidative stress in Alzheimer disease. Arch Neurol. 1999;56(12):1449–1452.[PubMed]

49. Perry G, Castellani RJ, Hirai K, Smith MA. Reactive oxygen species mediate cellular damage in Alzheimer disease. J Alzheimers Dis. 1998;1(1):45–55.[PubMed]

50. Moreira PI, Harris PL, Zhu X, Santos MS, Oliveira CR, Smith MA, et al. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J Alzheimers Dis. 2007;12(2):195–206.[PubMed]

51. Moreiraa PI, Carvalhob C, Zhuc X, Smithc MA, Perryd G. Mitochondrial dysfunction is a trigger of Alzheimer’s disease pathophysiology. Biochim Biophys Acta. 2010;1802(1):2–10.[PubMed]

52. Hardas SS, Sultana R, Clark AM, Beckett TL, Szweda LI, Murphy MP, et al. Oxidative modification of lipoic acid by HNE in Alzheimer disease brain. Redox Biol. 2013;1:80–85.[PMC free article][PubMed]

53. Kerksick C, Willoughby D. The Antioxidant role of glutathione and N-acetyl cysteine supplements and exerciseinduced oxidative stress. J Int Soc Sports Nutr. 2005;2:38–44.[PMC free article][PubMed]

54. Agid Y, Ruberg M, Javoy-Agid F, Hirsch E, Raisman-Vozari R, Vyas S, et al. Are dopaminergic neurons selectively vulnerable to Parkinson’s disease? Adv Neurol. 1993;60:148–164.[PubMed]

55. Veldman BA, Wijn AM, Knoers N, Praamstra P, Horstink MW. Genetic and environmental risk factors in Parkinson’s disease. Clin Neurol Neurosurg. 1998;100(1):15–26.[PubMed]

56. Williams AC, Smith ML, Waring RH, Ramsden DB. Idiopathic Parkinson’s disease: a genetic and environmental model. Adv Neurol. 1999;80:215–218.[PubMed]

57. Bowling AC, Mutisya EM, Walker LC, Price DL, Cork LC, Beal MF. Age-dependent impairment of mitochondrial function in primate brain. J Neurochem. 1993;60(5):1964–1967.[PubMed]

58. Curti D, Giangare MC, Redolfi ME, Fugaccia I, Benzi G. Age-related modification of cytochrome c oxidase activity in discrete brain regions. Mech Ageing Dev. 1990;55(2):171–180.[PubMed]

59. Martinez-Banclocha MA. N-acetyl cysteine in the treatment of Parkinson’s disease.What are we waiting for? Med Hypotheses. 2012;79(1):8–12.[PubMed]

60. Shahripour RB, Harrigan MR, Alexandrov AV. N-acetyl cysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain Behav. 2014;4(2):108–122.[PMC free article][PubMed]

61. Dehay B, Bourdenx M, Gorry P, Przedborski S, Vila M, Hunot S, et al. Targeting α-synuclein for treatment of Parkinson’s disease: mechanistic and therapeutic considerations. Lancet Neurol. 2015;14(8):855–866.[PMC free article][PubMed]

Citation data is made available by participants in Crossref's Cited-by Linking service. For a more comprehensive list of citations to this article, users are encouraged to perform a search inSciFinder.

  • Activatable QD-Based Near-Infrared Fluorescence Probe for Sensitive Detection and Imaging of DNA

    YizhongShenNanZhangYidanSunWei-WeiZhaoDejuYeJing-JuanXuHong-YuanChen

    ACS Applied Materials & Interfaces20179 (30), 25107-25113

    Abstract | Full Text HTML | PDF | PDF w/ Links

  • Characterization of Indium Phosphide Quantum Dot Growth Intermediates Using MALDI-TOF Mass Spectrometry

    LisiXieYiShenDanielFrankeVíctorSebastiánMoungi G.BawendiKlavs F.Jensen

    Journal of the American Chemical Society2016138 (41), 13469-13472

    Abstract | Full Text HTML | PDF | PDF w/ Links

  • Effect of growth temperature on the structural, optical and luminescence properties of cadmium telluride nanoparticles

    SharonKiprotichMartin O.OnaniFrancis B.Dejene

    Journal of Materials Science: Materials in Electronics201832,

  • Wet Chemical Synthesis Methods

    AbdulMajidMaryamBibi

    2018,43-101

  • Preparation of Highly Biocompatible ZnSe Quantum Dots Using a New Source of Acetyl Cysteine as Capping Agent

    EhsanSoheyliRezaSahraeiGholamrezaNabiyouni

    Journal of Fluorescence201727 (5), 1581-1586

  • Recent developments on the synthesis, structural and optical properties of chalcogenide quantum dots

    SubhashChandNageshThakurS.C.KatyalP.B.BarmanVineetSharmaPankajSharma

    Solar Energy Materials and Solar Cells2017168, 183-200

  • Synthesis and optical properties of cysteamine-capped ZnS quantum dots for aflatoxin quantification

    MohammadTavakkoli YarakiMahnoushTayebiMahnazAhmadiehMohammadrezaTahririDaryooshVashaeeLobatTayebi

    Journal of Alloys and Compounds2017690, 749-758

  • An organometallic route to chiroptically active ZnO nanocrystals

    ElżbietaChwojnowskaMałgorzataWolska-PietkiewiczJustynaGrzonkaJanuszLewiński

    Nanoscale20179 (39), 14782-14786

  • Aqueous based synthesis of N-acetyl- l -cysteine capped ZnSe nanocrystals with intense blue emission

    EhsanSoheyliRezaSahraeiGholamrezaNabiyouni

    Optical Materials201660, 564-570

  • Seed-mediated growth approach for rapid synthesis of high-performance red-emitting CdTe quantum dots in aqueous phase and their application in detection of highly reactive oxygen species

    YaliXuJunjieHaoXiaoyingNiuShengdaQiHongliChenKaiWangXingguoChenTaoYi

    Chemical Engineering Journal2016299, 201-208

  • Synthesis and characterization of high-quality water-soluble CdMnTe quantum dots capped by N-acetyl-L-cysteine through hydrothermal method

    FangGaoJiaotianLiFengxueWangTanmingYangDanZhao

    Journal of Luminescence2015159, 32-37

  • One-Step Synthesis of High-Quality Water-Soluble CdSe Quantum Dots Capped by N -Acetyl-L-cysteine via Hydrothermal Method and Their Characterization

    ChunjinWeiJinyuLiFangGaoShuxiaGuoYongcuiZhouDanZhao

    Journal of Spectroscopy20152015, 1-7

  • Synthesis of N-acetyl-L-cysteine-capped ZnCdSe quantum dots via hydrothermal method and their characterization

    FangGaoYuyingLiuYaoFanDanZhao

    Science and Technology of Advanced Materials201415 (5), 055001

  • One thought on “N Acetyl Cysteine Synthesis Essay

    Leave a comment

    L'indirizzo email non verrà pubblicato. I campi obbligatori sono contrassegnati *